Theriva Biologics
TOVX
TOVX
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BIM
26
BlackRock Investment Management
Wilmington,
Delaware
| $13K | +$15.9K | +1 | New |
|
|
U
27
UBS
Zurich,
Switzerland
| $6K | – | – | – |
|
|
GT
28
Glenmede Trust
Philadelphia,
Pennsylvania
| $4K | – | – | – |
|
29
BNP Paribas Financial Markets
Paris,
France
| $1.9K | – | – | – |
|
30
Citigroup
New York
| $1K | – | – | – |
|
|
GSC
31
Ground Swell Capital
Folly Beach,
South Carolina
| $1K | – | – | – |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| $1K | – | – | – |
|
|
EI
33
EAM Investors
Solana Beach,
California
| – | -$1.14M | -51 | Closed |
|
34
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$360K | -16 | Closed |
|
|
LP
35
LMR Partners
London,
United Kingdom
| – | -$257K | -11 | Closed |
|
|
CS
36
Credit Suisse
Zurich,
Switzerland
| – | -$176K | -8 | Closed |
|
37
Wells Fargo
San Francisco,
California
| – | -$64K | -3 | Closed |
|
38
US Bancorp
Minneapolis,
Minnesota
| – | -$1K | – | – |
|